← SynDRA
ALDOXORUBICIN
SynDRA canonical compound SYN0033263 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | TOP2A |
| Mechanism of action | topoisomerase inhibitor |
All known targets
Mechanisms of action (all sources)
- TOP2A INHIBITOR
- DNA topoisomerase II alpha inhibitor
- topoisomerase inhibitor
- Modulator
Cross-references
Synonyms
- Aldoxorubicine
- Aldoxorubicina
- Doxo-emch
- Doxorubicin-emch
- Inno-206
- Doxorubicin-EMCH
- Aldoxorubicin (USAN)
- CHEMBL2107818
- SCHEMBL15221892
- OBMJQRLIQQTJLR-LBMCFUDOSA-N
- ZINC163337436
- AKOS030526452
- CS-1186
- HY-16261
- D10383
- W-5595
- (8S)-1-Methoxy-6,8alpha,11-trihydroxy-8-[1-[2-[6-(2,5-dioxo-3-pyrroline-1-yl)hexanoyl]hydrazono]-2-hydroxyethyl]-10alpha-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-7,8,9,10-tetrahydronaphthacene-5,12-dione
- INNO-206
- aldoxorubicine
- aldoxorubicina
- C28MV4IM0B
- aldoxorubicinum
- RefChem:110649
- INNO206
- MFCD15146982
- Aldoxorubicin [USAN]
- adoxorubicin
- C37H42N4O13
- Aldoxorubicin hydrochlorid
- ALDOXORUBICIN [INN]
- Aldoxorubicin (USAN/INN)
- ALDOXORUBICIN [WHO-DD]
- orb1709837
- SCHEMBL29464030
- EX-A3971
- AC9042
- NSC784722
- AKOS040733017
- NSC-784722
Look up ALDOXORUBICIN in the interactive SynDRA portal →